Tag: Irreversible antiplatelets

Antiplatelet therapy reduces the risk of serious cardiovascular events such as heart attacks and strokes. A defining feature of certain antiplatelets is irreversible inhibition, meaning their effect lasts for the entire lifespan of the affected platelet, typically 7–10 days. For these drugs, understanding exactly which antiplatelets are irreversible is crucial for patient safety and clinical management.

With the global antiplatelet market projected to reach $5.1 billion by 2030, understanding their properties is crucial [1.10.1]. The critical question for clinicians and patients alike is, **are antiplatelets reversible**, and what does that mean for managing bleeding or emergency surgery?